Gabriela Denning

Expression Therapeutics

$2,318,112

Attributed

$6,204,490

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2012–19

$2M$1.5M$1M$500K$0

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$6,204,490 · 9

By mechanism

R44$4,469,084 · 3

R43$1,735,406 · 6

Top collaborators

Most similar at Expression Therapeutics

Same institution · by research overlap

Christopher Bradley Doering$9,776,945

Others in their field

Top investigators on “Factor Viii”

Stephen Kevin Burley · Sgx Pharmaceuticals, Inc.$46,173,838
Carol H Miao · Seattle Children'S Hospital$20,522,869
Randal J. Kaufman · Indiana University Indianapolis$17,115,477
John H Sampson · Duke University$16,869,951
John P Phair · Northwestern University$14,665,395
Roland W. Herzog · Indiana University Indianapolis$14,011,353

Research focus

Factor ViiiSmall Business Innovation Research GrantHemophilia ADesignBiomedical EngineeringSafetyRecombinantsCellsBlood Coagulation FactorProductionTechnologyRecombinant Antihemophilic Factor ViiiPre-ClinicalPersonsBaseFamily SuidaeRunningProteinsPropertyTransgenesCommercializationMeetingsCostCell Line